MEDINDIA
English
हिन्दी
Español
français
中文
Age is the biggest risk factor for dementia. As the life expectancy increases, the number of people with dementia is likely to increase.
Inability to Recognize Familiar Smells Could Signal Alzheimers
People who have difficulty recognizing familiar smells could be experiencing an early sign of Alzheimer's disease, according to a study published Monday.
People who have difficulty recognizing familiar smells could be experiencing an early sign of Alzheimer's disease, according to a study published Monday.
Dementia is caused by brain diseases, most commonly Alzheimer’s disease, which results in the loss of brain cells and affects memory, thinking, behavior and the ability to perform day to day activities.
Age is the biggest risk factor for dementia. As the life expectancy increases, the number of people with dementia is likely to increase.
Risk Factors for Alzheimers Disease
Cognitively normal adults exhibiting atrophy of their temporal lobe or damage to blood vessels in the brain are more likely to develop Alzheimer’s disease.
Cognitively normal adults exhibiting atrophy of their temporal lobe or damage to blood vessels in the brain are more likely to develop Alzheimer’s disease.
Mark Dallas, a neuroscientist at Britain's University of Reading who specializes in Alzheimer's, said that this study highlighted the gaps in research efforts and funds.
Baxter Admits Experimental Alzheimer�s Treatment is Unsuccessful
American pharmaceutical giant Baxter revealed that its experimental treatment that could have slowed down the mental impairment in Alzheimer’s disease patients has been unsuccessful.
American pharmaceutical giant Baxter revealed that its experimental treatment that could have slowed down the mental impairment in Alzheimer’s disease patients has been unsuccessful.
Source-Medindia
Brain Protein Could be Targeted to Slow Alzheimer�s, Study Reveals
A protein that is involved in limiting flexibility in the aging brain could be targeted by new treatments which can slow the progression of Alzheimer’s disease.
A protein that is involved in limiting flexibility in the aging brain could be targeted by new treatments which can slow the progression of Alzheimer’s disease.
Email
